American became the first person in the world to receive an experimental vaccine from COVID-19
IgorVetushko / DepositPhotos
The President of the United States Donald trump personally has not contacted Haller, but footage of her vaccination was used in 30-second clip about the leading role of trump in a time of crisis
Freeze video The White House / Youtube.com
44-year-old American Jennifer Haller was the first person in the world to receive an experimental vaccine against coronavirus mRNA-1273, developed at the National Institute of Allergy and infectious diseases in Seattle (USA) together with the biotech company Moderna. To tests on volunteers, the drug has been tested successfully on animals.
Haller decided to respond to an ad in Facebook for volunteers and was one of 45 volunteers selected to participate in the study. Before receiving authorization to participate, the American passed medical exams and signed a 45-page disclaimer, warning about the risks and possible infection with coronavirus in the future, writes The Telegraph.
The first injection Haller received March 16, he COVID-19 she did not enter. The procedure took a few seconds. In the following weeks asked her every day to keep a diary of observations of their feelings. According to Haller, the first day she had a little fever on the second is very sick hand (the drug was administered in the left shoulder), then the state is normalized. “It was as easy as in normal flu vaccine,” – said the woman.
The second injection injected after 28 days, the Haller will receive it next week. Then she has the year seen the doctors. In connection with participation in the American experiment comes to a lot of messages in social networks with thanks and words of support. The President of the United States Donald trump personally has not contacted Haller, but footage of her vaccination was used in 30-second clip about the leading role of trump during the crisis.
The world health organization (who) declared that pandemic coronavirus will continue until you develop a vaccine, and it will be ready not earlier than in a year. While it is not known exactly, it can’t develop the immunity in those who are already ill. The development of a vaccine against the coronavirus involved several countries, including USA, UK, France, China, Russia.
In Russia the vaccine develop seven research centers, said the Minister of health of the Russian Federation Mikhail Murashko. According to him, “there are already first results”, clinical trial is scheduled to begin in the near future. At the same time, he noted that while it is impossible with absolute certainty to say that the doctors have the drug from the coronavirus that can be used for the treatment and prevention of infection.
State research center of Virology and biotechnology “Vector” vaccine prototypes already tested on mice and ferrets, by the summer plans to begin testing on humans. According to the Director of the centre of Rinat Maksutov, has formed a list of 60 volunteers. Among them are the developers of the vaccine, “because they believe in their effectiveness, and security.”
One of the volunteers, the chief developer of vaccines Ilnaz Gimatdinov told that scientists had based the sequence coding for the surface spike from viral particles, many of which formed the so-called crown. “We tore it and placed the gene encoding the protein, into the genome of cells-producers. So, we are now able to accumulate the protein in unlimited quantities in a safe environment,” said Gimatdinov in a documentary TV channel “Russia-1” “download – 2”.
China has allowed clinical trials of three vaccines. At the end of March ended the initial testing of the first vaccine based on adenovirus vector. April 9, began the recruitment of volunteers to conduct second phase clinical trials. The world’s first vaccine against the coronavirus, which has moved to the secondary clinical tests, said on 14 April, the representative of the Ministry of science and technology of China Have Wangbing.
Also approved application for primary and secondary clinical trials of inactivated vaccine against new type of coronavirus (Vero cell), developed by Wuhan Institute of Biological Products, part of Sinopharm Corporation. The permit test also received a Chinese biopharmaceutical company Sinovac Biotech. Sinopharm is working on two vaccines against coronavirus: inactivated and genetically engineered (recombinant).